1,4,5 A network meta-analysis of randomised controlled trials comparing the effects of anti-hyperglycaemic medications on muscle mass in people with T2D revealed that 40% of the weight lost through GLP-1 medications (Semaglutide) is fat free mass including skeletal muscle
The webinar will be held on August 21 at 12:00 p.m
July 10, 2026 - Reminder: ADA Site Visit Attestation Completion Required Recently, we experienced technical issues that impacted access to our attestation form
However, the fatty alteration of hepatocytes in the HF+Lira group was significantly improved
Layer P, Peschel S, Schlesinger T, and Goebell H
Cell-based experiments also demonstrate receptor-dependent signaling changes when Retatrutide interacts with GLP-1R, GIPR, or GCGR expressing cells